INNOVATION1 BIOTECH INC. Research and Development Expense
INNOVATION1 BIOTECH INC. reported Research and Development Expense of $0 for the 3-month period ending 2023-11-30, per its 10-Q filed 2025-01-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-05-06
- INNOVATION1 BIOTECH INC. research and development expense for the quarter ending 2023-11-30 was $0.00, a 100.00% decline year-over-year.
- INNOVATION1 BIOTECH INC. research and development expense for the quarter ending 2023-08-31 was $0.00, a 100.00% decline year-over-year.
- INNOVATION1 BIOTECH INC. research and development expense for the quarter ending 2023-05-31 was $0.00.
- INNOVATION1 BIOTECH INC. research and development expense for the quarter ending 2023-02-28 was $0.00.
- INNOVATION1 BIOTECH INC. research and development expense for fiscal 2023 was $15.00K, a 92.54% decline from fiscal 2022.
- INNOVATION1 BIOTECH INC. research and development expense for fiscal 2022 was $201.17K.
- INNOVATION1 BIOTECH INC. research and development expense for fiscal 2021 was $0.00.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2023-11-30 | $0.00 10-Q · filed 2025-01-27 | $0.00 derived: sum of 2 quarters · filed 2025-01-27 | $0.00 derived: sum of 3 quarters · filed 2025-01-27 | $0.00 derived: sum of 4 quarters · filed 2025-01-27 | |
| 2023-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-17 | $0.00 derived: sum of 2 quarters · filed 2024-01-17 | $0.00 derived: sum of 3 quarters · filed 2024-01-17 | $15.00K 10-K · filed 2024-01-17 | |
| 2023-05-31 | $0.00 10-Q · filed 2023-09-13 | $0.00 derived: sum of 2 quarters · filed 2023-09-13 | $15.00K 10-Q · filed 2023-09-13 | $216.17K derived: sum of 4 quarters · filed 2025-01-27 | |
| 2023-02-28 | $0.00 10-Q · filed 2023-05-30 | $15.00K 10-Q · filed 2025-05-06 | $216.17K derived: sum of 3 quarters · filed 2025-01-27 | $216.17K derived: sum of 4 quarters · filed 2025-01-27 | |
| 2022-11-30 | $15.00K 10-Q · filed 2025-01-27 | $216.17K derived: sum of 2 quarters · filed 2025-01-27 | $216.17K derived: sum of 3 quarters · filed 2025-01-27 | $216.17K derived: sum of 4 quarters · filed 2025-01-27 | |
| 2022-08-31 | $201.17K derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-17 | $201.17K derived: sum of 2 quarters · filed 2024-01-17 | $201.17K derived: sum of 3 quarters · filed 2024-01-17 | $201.17K 10-K · filed 2024-01-17 | $201.16K 10-K · filed 2022-12-15 |
| 2022-05-31 | $0.00 10-Q · filed 2023-09-13 | $0.00 derived: sum of 2 quarters · filed 2023-09-13 | $0.00 10-Q · filed 2023-09-13 | ||
| 2022-02-28 | $0.00 10-Q · filed 2023-05-30 | $0.00 10-Q · filed 2023-05-30 | |||
| 2021-11-30 | $0.00 10-Q · filed 2023-01-17 | ||||
| 2021-08-31 | $0.00 10-K · filed 2022-12-15 |